Phase 1 biotech developing small molecule therapies for rare muscle disorders.
Industry: Health Care
First Day Return: +87.5%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 03/05/2021 |
Offer Price | $16.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 11.0 |
Deal Size ($mm) | $176 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 03/25/2021 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $176 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Boulder, CO, United States |
Founded | 2017 |
Employees at IPO | 19 |
Website www.edgewisetx.com |